Project Grant HT94252410062
- The Johns Hopkins University was awarded a $1.14 million project grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from September 2022 through September 2025 to develop a novel non-surgical neuro-immunomodulatory treatment for acquired hydrocephalus. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the goals of...
- This Project Grant award of $319,601.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research at Wayne State University focused on the effects of biological versus chronological aging on mobility and cognition in individuals with multiple sclerosis. The research, to be conducted from November 1, 2025 to October 31, 2027, aims to transform healthcare for military service members, veterans, and the broader public by advancing...
- This Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) provides $400,400 to Wayne State University in Detroit, MI to conduct research on "Harnessing Immunometabolism to Ameliorate the Pathology of Ocular Chemical Injuries". The project aims to transform healthcare for military service members and the broader public by advancing innovative biomedical research on addressing medical challenges relevant to the military. The...
- The University of Southern California (USC) was awarded a $3,296,634.00 Project Grant from the Defense Health Agency to conduct research on "ACTIVATION OF BRAIN LYMPHATIC DRAINAGE THROUGH PIEZO1-CONTROLLED MECHANOTRANSDUCTION AS A NOVEL HYDROCEPHALUS THERAPY". The grant, which commenced on September 1, 2023 and will be completed by August 31, 2027, is funded through the Military Medical Research and Development (CFDA 12.420) program. This research aims to investigate medical...
- The U.S. Defense Health Agency awarded a $4,626,921 Project Grant to The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. under the Military Medical Research and Development program (CFDA 12.420). The grant, with a performance period of August 1, 2025 to July 31, 2028, will fund research to elucidate the role of the neurovascular unit and related structural and functional neurological sequelae after exposure to repeated blast. This research aims to transform...
- This $377,227 Project Grant was awarded on August 15, 2024 by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. The prime awardee, Florida State University, will conduct research related to traumatic brain injury and psychological health. The funded project aims to develop innovative...
- The Defense Health Agency awarded a $1,493,220 Project Grant to The Cleveland VA Medical Research & Education Foundation under the Military Medical Research and Development program (CFDA 12.420). The grant supports the development of a "Neurally Integrated Lower Limb Prosthesis for Home and Community Use" to aid mobility and sensory restoration for wounded veterans. The 4-year project, running from September 2023 to August 2027, aligns with the program's priorities of advancing...
- The Johns Hopkins University was awarded a $1,146,159 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will fund research from September 30, 2022 to September 29, 2025 to develop a novel non-surgical neuro-immunomodulatory treatment for acquired hydrocephalus. The Military Medical Research and Development program supports basic, applied, and advanced biomedical research with the...
- This federal Project Grant award of $1,868,800.00, provided by the Defense Health Agency through the Military Medical Research and Development program (CFDA 12.420), supports research to investigate the effect of cardiocentric hemodynamic management on cardiovascular outcomes for individuals with acute cervical spinal cord injury. The award was made to the University of British Columbia's Research Services division, which has a history of conducting advanced biomedical research for federal...
- The Department of Defense's Military Medical Research and Development program (CFDA 12.420) has awarded a $7,693,599 project grant to the University of Texas Health Science Center at Houston (UTHealth). The award, with a period of performance from Sep 15, 2023 to Sep 14, 2027, will fund research to study "Trauma-Induced Coagulopathy and the Blood-Brain Barrier: Impact of Resuscitation." As the prime grantee, UTHealth will leverage its expertise in biomedical research, clinical...
This $307,202 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research by Wayne State University to optimize shunt catheters for the treatment of hydrocephalus. The award, with an initial term from January 15, 2024 to January 14, 2026, will fund experimental, computational, and analytical studies focused on biomechanics, human injury tolerance, anthropomorphic test device evaluation, and computational modeling using human and test dummy models. This work aims to advance the understanding of human crash response, injury risk, and vehicle safety to ultimately improve treatments for hydrocephalus, a condition commonly affecting military service members and veterans.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $307.2k | 12/19/23 |